Smith & Nephew plc (LON:SN) was downgraded by research analysts at Berenberg Bank to a “hold” rating in a research report issued on Thursday. They currently have a GBX 1,340 ($17.49) target price on the stock, down from their previous target price of GBX 1,485 ($19.38). Berenberg Bank’s price target points to a potential upside of 7.98% from the stock’s current price.

SN has been the subject of several other reports. JPMorgan Chase & Co. reiterated a “neutral” rating and set a GBX 1,199 ($15.65) target price on shares of Smith & Nephew plc in a research report on Wednesday, September 14th. Jefferies Group lifted their target price on Smith & Nephew plc from GBX 1,375 ($17.95) to GBX 1,420 ($18.54) and gave the stock a “buy” rating in a research report on Thursday, June 30th. Goldman Sachs Group Inc. reiterated a “buy” rating on shares of Smith & Nephew plc in a research report on Tuesday, September 13th. BNP Paribas reiterated an “outperform” rating and set a GBX 1,335 ($17.43) target price on shares of Smith & Nephew plc in a research report on Monday, June 27th. Finally, Numis Securities Ltd reiterated an “add” rating and set a GBX 1,242 ($16.21) target price on shares of Smith & Nephew plc in a research report on Friday, June 24th. Ten research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of GBX 1,283.77 ($16.76).

Analyst Recommendations for Smith & Nephew plc (LON:SN)

Shares of Smith & Nephew plc (LON:SN) traded up 1.55% during mid-day trading on Thursday, reaching GBX 1241.00. 5,498,810 shares of the company traded hands. Smith & Nephew plc has a 52 week low of GBX 1,040.36 and a 52 week high of GBX 1,324.00. The firm has a 50 day moving average of GBX 1,239.11 and a 200-day moving average of GBX 1,208.89. The stock’s market capitalization is GBX 11.09 billion.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

In other Smith & Nephew plc news, insider Bottomley ,Virginia purchased 238 shares of the company’s stock in a transaction dated Monday, August 15th. The shares were acquired at an average price of GBX 1,290 ($16.84) per share, for a total transaction of £3,070.20 ($4,007.57).

About Smith & Nephew plc

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. The Company offers various product franchises, which include Knee implants, Hip implants, Sports Medicine Joint Repair, Arthroscopy Enabling Technologies, Trauma and Extremities, Other Surgical Businesses, Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives.

Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with's FREE daily email newsletter.